BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28747057)

  • 1. Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease.
    Hernández-Tejero M; Granja Navacerrada A; Bernal Checa P; Piqué Becerra R; Algaba García A; Guerra Marina I; García-Alonso FJ; Syed M; Bermejo F
    Rev Esp Enferm Dig; 2017 Sep; 109(9):627-633. PubMed ID: 28747057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the "Clementino Fraga Filho" University Hospital, Rio de Janeiro, RJ, Brazil].
    Elia PP; Fogaça HS; Barros RG; Zaltman C; Elia CS
    Arq Gastroenterol; 2007; 44(4):332-9. PubMed ID: 18317653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gut-liver axis in inflammatory bowel disease. A retrospective study].
    Egresi A; Kovács Á; Szilvás Á; Blázovics A
    Orv Hetil; 2017 Jul; 158(26):1014-1021. PubMed ID: 28651460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.
    Moravvej H; Razavi GM; Farshchian M; Malekzadeh R
    Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
    Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
    World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscoloskeletal manifestations in inflammatory bowel disease.
    Fornaciari G; Salvarani C; Beltrami M; Macchioni P; Stockbrügger RW; Russel MG
    Can J Gastroenterol; 2001 Jun; 15(6):399-403. PubMed ID: 11429669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.
    Thiebault H; Boyard-Lasselin P; Guignant C; Guillaume N; Wacrenier A; Sabbagh C; Rebibo L; Brazier F; Meynier J; Nguyen-Khac E; Dupas JL; Goëb V; Fumery M
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):876-81. PubMed ID: 27101404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007.
    Vahedi H; Merat S; Momtahen S; Olfati G; Kazzazi AS; Tabrizian T; Rashtak S; Khaleghnejad R; Khademi H; Malekzadeh F; Nasseri-Moghaddam S; Malekzadeh R
    Arch Iran Med; 2009 Sep; 12(5):454-60. PubMed ID: 19722766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.
    Severs M; van Erp SJ; van der Valk ME; Mangen MJ; Fidder HH; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Bolwerk C; Vermeijden JR; Pierik MJ; Siersema PD; Leenders M; van der Meulen-de Jong AE; Dijkstra G; Oldenburg B;
    J Crohns Colitis; 2016 Apr; 10(4):455-61. PubMed ID: 26721937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.
    Fine S; Nee J; Thakuria P; Duff B; Farraye FA; Shah SA
    Dig Dis Sci; 2017 Dec; 62(12):3269-3279. PubMed ID: 29064013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study.
    De Galan C; Truyens M; Peeters H; Mesonero Gismero F; Elorza A; Torres P; Vandermeulen L; Amezaga AJ; Ferreiro-Iglesias R; Holvoet T; Zabana Y; Reverter LP; Gonzales GB; Geldof J; Varkas G; De Vos M; Lobatón T
    J Crohns Colitis; 2022 Nov; 16(11):1676-1686. PubMed ID: 35442433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-intestinal manifestations of Crohn's disease.
    Ephgrave K
    Surg Clin North Am; 2007 Jun; 87(3):673-80. PubMed ID: 17560419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uveitis and chronic intestinal inflammatory diseases: three case studies].
    Chaoui Z; Bernoussi A; Belmekki M; Berraho A
    J Fr Ophtalmol; 2005 Oct; 28(8):854-6. PubMed ID: 16249766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.